Tetsu Sakamoto

Tetsu Sakamoto

Auto-generated profile, based on publicly available information

Tetsu Sakamoto

Department of Diagnostic and Generalist Medicine, Dokkyo Medical University, Tochigi, Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
THTakanobu Hirosawa
Takanobu Hirosawa
Yukinori HaradaYukinori Harada
Yukinori Harada
MYMasashi Yokose
Masashi Yokose
TSTetsu Sakamoto
Tetsu Sakamoto
RKRen Kawamura
Ren Kawamura
TSTaro Shimizu
Taro Shimizu
The diagnostic accuracy of differential diagnoses generated by artificial intelligence (AI) chatbots, including the generative pretrained transformer 3 (GPT-3) chatbot (ChatGPT-3) is unknown. This study evaluated the accuracy of differential-diagnosis lists generated by ChatGPT-3 for clinical vignettes with common chief complaints. General internal medicine physicians created clinical cases, correct diagnoses, and five differential diagnoses for ten common chief complaints. The rate of correct diagnosis by ChatGPT-3 within the ten differential-diagnosis lists was 28/30 (93.3%). The rate of correct diagnosis by physicians was still superior to that by ChatGPT-3 within the five differential-diagnosis lists (98.3% vs. 83.3%, p = 0.03). The rate of correct diagnosis by physicians was also superior to that by ChatGPT-3 in the top diagnosis (53.3% vs. 93.3%, p < 0.001). The rate of consistent differential diagnoses among physicians within the ten differential-diagnosis lists generated by ChatGPT-3 was 62/88 (70.5%). In summary, this study demonstrates the high diagnostic accuracy of differential-diagnosis lists generated by ChatGPT-3 for clinical cases with common chief complaints. This suggests that AI chatbots such as ChatGPT-3 can generate a well-differentiated diagnosis list for common chief complaints. However, the order of these lists can be improved in the future.

26 June 2024 in JMIR Formative Research
Verified
Journal Article
Open access
THTakanobu Hirosawa
Takanobu Hirosawa
Yukinori HaradaYukinori Harada
Yukinori Harada
KMKazuya Mizuta
Kazuya Mizuta
TSTetsu Sakamoto
Tetsu Sakamoto
KTKazuki Tokumasu
Kazuki Tokumasu
TSTaro Shimizu
Taro Shimizu
Background: The potential of artificial intelligence (AI) chatbots, particularly ChatGPT with GPT-4 (OpenAI), in assisting with medical diagnosis is an emerging research area. However, it is not yet clear how well AI chatbots can evaluate whether the final diagnosis is included in differential diagnosis lists. Objective: This study aims to assess the capability of GPT-4 in identifying the final diagnosis from differential-diagnosis lists and to compare its performance with that of physicians for case report series. Methods: We used a database of differential-diagnosis lists from case reports in the American Journal of Case Reports, corresponding to final diagnoses. These lists were generated by 3 AI systems: GPT-4, Google Bard (currently Google Gemini), and Large Language Models by Meta AI 2 (LLaMA2). The primary outcome was focused on whether GPT-4’s evaluations identified the final diagnosis within these lists. None of these AIs received additional medical training or reinforcement. For comparison, 2 independent physicians also evaluated the lists, with any inconsistencies resolved by another physician. Results: The 3 AIs generated a total of 1176 differential diagnosis lists from 392 case descriptions. GPT-4’s evaluations concurred with those of the physicians in 966 out of 1176 lists (82.1%). The Cohen κ coefficient was 0.63 (95% CI 0.56-0.69), indicating a fair to good agreement between GPT-4 and the physicians’ evaluations. Conclusions: GPT-4 demonstrated a fair to good agreement in identifying the final diagnosis from differential-diagnosis lists, comparable to physicians for case report series. Its ability to compare differential diagnosis lists with final diagnoses suggests its potential to aid clinical decision-making support through diagnostic feedback. While GPT-4 showed a fair to good agreement for evaluation, its application in real-world scenarios and further validation in diverse clinical environments are essential to fully understand its utility in the diagnostic process.

27 November 2024 in JMIR Formative Research
Verified
Journal Article
Open access
TSTetsu Sakamoto
Tetsu Sakamoto
Yukinori HaradaYukinori Harada
Yukinori Harada
TSTaro Shimizu
Taro Shimizu
Background: Diagnostic errors are significant problems in medical care. Despite the usefulness of artificial intelligence (AI)–based diagnostic decision support systems, the overreliance of physicians on AI-generated diagnoses may lead to diagnostic errors. Objective: We investigated the safe use of AI-based diagnostic decision support systems with trust calibration by adjusting trust levels to match the actual reliability of AI. Methods: A quasi-experimental study was conducted at Dokkyo Medical University, Japan, with physicians allocated (1:1) to the intervention and control groups. A total of 20 clinical cases were created based on the medical histories recorded by an AI-driven automated medical history–taking system from actual patients who visited a community-based hospital in Japan. The participants reviewed the medical histories of 20 clinical cases generated by an AI-driven automated medical history–taking system with an AI-generated list of 10 differential diagnoses and provided 1 to 3 possible diagnoses. Physicians were asked whether the final diagnosis was in the AI-generated list of 10 differential diagnoses in the intervention group, which served as the trust calibration. We analyzed the diagnostic accuracy of physicians and the correctness of the trust calibration in the intervention group. We also investigated the relationship between the accuracy of the trust calibration and the diagnostic accuracy of physicians, and the physicians’ confidence level regarding the use of AI. Results: Among the 20 physicians assigned to the intervention (n=10) and control (n=10) groups, the mean age was 30.9 (SD 3.9) years and 31.7 (SD 4.2) years, the proportion of men was 80% and 60%, and the mean postgraduate year was 5.8 (SD 2.9) and 7.2 (SD 4.6), respectively, with no significant differences. The physicians’ diagnostic accuracy was 41.5% in the intervention group and 46% in the control group, with no significant difference (95% CI −0.75 to 2.55; P=.27). The overall accuracy of the trust calibration was only 61.5%, and despite correct calibration, the diagnostic accuracy was 54.5%. In the multivariate logistic regression model, the accuracy of the trust calibration was a significant contributor to the diagnostic accuracy of physicians (adjusted odds ratio 5.90, 95% CI 2.93‐12.46; P<.001). The mean confidence level for AI was 72.5% in the intervention group and 45% in the control group, with no significant difference. Conclusions: Trust calibration did not significantly improve physicians’ diagnostic accuracy when considering the differential diagnoses generated by reading medical histories and the possible differential diagnosis lists of an AI-driven automated medical history–taking system. As this was a formative study, the small sample size and suboptimal trust calibration methods may have contributed to the lack of significant differences. This study highlights the need for a larger sample size and the implementation of supportive measures of trust calibration.

12 May 2025 in JMIR Medical Education
Verified
Journal Article
Open access
THTakanobu Hirosawa
Takanobu Hirosawa
MYMasashi Yokose
Masashi Yokose
TSTetsu Sakamoto
Tetsu Sakamoto
Yukinori HaradaYukinori Harada
Yukinori Harada
KTKazuki Tokumasu
Kazuki Tokumasu
TSTaro Shimizu
Taro Shimizu
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: The medical interview remains a cornerstone of clinical training. There is growing interest in applying generative artificial intelligence (AI) in medical education, including medical interview training. However, its utility in culturally and linguistically specific contexts, including Japanese, remains underexplored. This study investigated the utility of generative AI for Japanese medical interview training. Objective: This pilot study aimed to evaluate the utility of generative AI as a tool for medical interviews training by comparing its performance with that of traditional face-to-face training methods using a simulated patient. Methods: We conducted a randomized crossover pilot study involving 20 postgraduate year 1-2 physicians from a university hospital. Participants were randomly allocated into two groups. Group A began with an AI-based station on a case involving abdominal pain, followed by a traditional station with a standardized patient presenting chest pain. Group B followed the reverse order, starting with the traditional station for abdominal pain, and subsequently within AI-based station for the chest pain scenario. In the AI-based stations, participants interacted with a GPTs-configured platform that simulated patient behaviors. GPTs are customizable versions of ChatGPT adapted for specific purposes. The traditional stations involved face-to-face interviews with a simulated patient. Both groups used identical, standardized case scenarios to ensure uniformity. Two independent evaluators, blinded to the study conditions, assessed participants' performances using six defined metrics: patient care and communication, history taking, physical examination, accuracy and clarity of transcription, clinical reasoning, and patient management. A 6-point Likert scale was employed for scoring. Discrepancy between the evaluators resolved through discussion. To ensure cultural and linguistic authenticity, all interviews and evaluations were conducted in Japanese. Results: AI-based stations scored lower across most categories, particularly in patient care and communication, than traditional stations (4.48 vs. 4.95, P=.009). However, AI-based stations demonstrated comparable performance in clinical reasoning, with a non-significant difference (4.43 vs. 4.85, P=.10). Conclusions: The comparable performance of generative AI in clinical reasoning highlights its potential as a complementary tool in medical interview training. One of its main advantages lies in enabling self-learning, allowing trainees to independently practice interviews without the need for simulated patients. Nonetheless, the lower scores in patient care and communication underline the importance of maintaining traditional methods that capture the nuances of human interaction. These findings support the adoption of hybrid training models that combine generative AI with conventional approaches to enhance the overall effectiveness of medical interview training in Japan. Clinical Trial: UMIN-CTR UMIN000053747; https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061336.

17 May 2024 in JMIR Formative Research
Verified
Journal Article
Open access
Yukinori HaradaYukinori Harada
Yukinori Harada
TSTetsu Sakamoto
Tetsu Sakamoto
SSShu Sugimoto
Shu Sugimoto
TSTaro Shimizu
Taro Shimizu
Background: Artificial intelligence (AI) symptom checker models should be trained using real-world patient data to improve their diagnostic accuracy. Given that AI-based symptom checkers are currently used in clinical practice, their performance should improve over time. However, longitudinal evaluations of the diagnostic accuracy of these symptom checkers are limited. Objective: This study aimed to assess the longitudinal changes in the accuracy of differential diagnosis lists created by an AI-based symptom checker used in the real world. Methods: This was a single-center, retrospective, observational study. Patients who visited an outpatient clinic without an appointment between May 1, 2019, and April 30, 2022, and who were admitted to a community hospital in Japan within 30 days of their index visit were considered eligible. We only included patients who underwent an AI-based symptom checkup at the index visit, and the diagnosis was finally confirmed during follow-up. Final diagnoses were categorized as common or uncommon, and all cases were categorized as typical or atypical. The primary outcome measure was the accuracy of the differential diagnosis list created by the AI-based symptom checker, defined as the final diagnosis in a list of 10 differential diagnoses created by the symptom checker. To assess the change in the symptom checker’s diagnostic accuracy over 3 years, we used a chi-square test to compare the primary outcome over 3 periods: from May 1, 2019, to April 30, 2020 (first year); from May 1, 2020, to April 30, 2021 (second year); and from May 1, 2021, to April 30, 2022 (third year). Results: A total of 381 patients were included. Common diseases comprised 257 (67.5%) cases, and typical presentations were observed in 298 (78.2%) cases. Overall, the accuracy of the differential diagnosis list created by the AI-based symptom checker was 172 (45.1%), which did not differ across the 3 years (first year: 97/219, 44.3%; second year: 32/72, 44.4%; and third year: 43/90, 47.7%; P=.85). The accuracy of the differential diagnosis list created by the symptom checker was low in those with uncommon diseases (30/124, 24.2%) and atypical presentations (12/83, 14.5%). In the multivariate logistic regression model, common disease (P<.001; odds ratio 4.13, 95% CI 2.50-6.98) and typical presentation (P<.001; odds ratio 6.92, 95% CI 3.62-14.2) were significantly associated with the accuracy of the differential diagnosis list created by the symptom checker. Conclusions: A 3-year longitudinal survey of the diagnostic accuracy of differential diagnosis lists developed by an AI-based symptom checker, which has been implemented in real-world clinical practice settings, showed no improvement over time. Uncommon diseases and atypical presentations were independently associated with a lower diagnostic accuracy. In the future, symptom checkers should be trained to recognize uncommon conditions.

4 December 2025 in JMIR Formative Research
Verified
Journal Article
Open access
MYMasashi Yokose
Masashi Yokose
THTakanobu Hirosawa
Takanobu Hirosawa
TSTetsu Sakamoto
Tetsu Sakamoto
RKRen Kawamura
Ren Kawamura
YSYudai Suzuki
Yudai Suzuki
TSTaro Shimizu
Taro Shimizu
Background: The Objective Structured Clinical Examination (OSCE) has been widely used to evaluate students in medical education. However, it is resource-intensive, presenting challenges in implementation. We hypothesized that generative artificial intelligence (AI) such as ChatGPT-4 could serve as a complementary assessor and alleviate the burden of physicians in evaluating OSCE. Objective: By comparing the evaluation scores between generative AI and physicians, this study aims to evaluate the validity of generative AI as a complementary assessor for OSCE. Methods: This experimental study was conducted at a medical university in Japan. We recruited 11 fifth-year medical students during the general internal medicine clerkship from April 2023 to December 2023. Participants conducted a mock medical interview with a patient experiencing abdominal pain and wrote patient notes. Four physicians independently evaluated the participants by reviewing medical interview videos and patient notes, while ChatGPT-4 was provided with interview transcripts and notes. Evaluations were conducted using the 6-domain rubric (patient care and communication, history taking, physical examination, patient notes, clinical reasoning, and management). Each domain was scored using a 6-point Likert scale, ranging from 1 (very poor) to 6 (excellent). Median scores were compared using the Wilcoxon signed-rank test, and the agreement between ChatGPT-4 and physicians was assessed using intraclass correlation coefficients (ICCs). All P values <.05 were considered statistically significant. Results: Although ChatGPT-4 assigned higher scores than physicians in terms of physical examination (median 4.0, IQR 4.0-5.0 vs median 4.0, IQR 3.0-4.0; P=.02), patient notes (median 6.0, IQR 5.0-6.0 vs median 4.0, IQR 4.0-4.0; P=.002), clinical reasoning (median 5.0, IQR 5.0-5.0 vs median 4.0, IQR 3.0-4.0; P<.001), and management (median 6.0, IQR 5.0-6.0 vs median 4.0, IQR 2.5-4.5; P=.002), there were no significant differences in the scores of patient care and communication (median 5.0, IQR 5.0-5.0 vs median 5.0, IQR 4.0-5.0; P=.06) and history taking (median 5.0, IQR 4.0-5.0 vs median 5.0, IQR 4.0-5.0; P>.99), respectively. ICC values were low in all domains, except for history taking, where the agreement was still poor (ICC=0.36, 95% CI –0.32 to 0.78). Conclusions: ChatGPT-4 produced higher evaluation scores than physicians in several OSCE domains, though the agreement between them was poor. Although these preliminary results suggest that generative AI may be able to support assessment in some domains of OSCE, further research is needed to establish its reproducibility and validity. Generative AI like ChatGPT-4 shows potential as a complementary assessor for OSCE. Trial Registration: University Hospital Medical Information Network Clinical Trials Registry UMIN000050489; https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr_his_list.cgi?recptno=R000057513